Akanda Corp.
AKAN- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- SEC CIK
- 0001888014
No open-market purchases or sales by Akanda Corp. insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $3.02K in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −3 vs. previous quarter
- 3
- 13F valueReported value at the end of Q2 2026
- $3.02K
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding AKAN, Q2 2026
No superinvestor reported holding AKAN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Akanda Corp. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 20, 2026 (view filing) | Jan 15 | 5 days | HRT Financial LP10% Owner | PPurchaseClass A Shares | +29.0K | $1.40 | +$40.7K | New position15.7K after | |
| Jan 20, 2026 (view filing) | Jan 16 | 4 days | HRT Financial LP10% Owner | SSaleClass A Shares | −7.87K | $1.29 | −$10.1K | −50.2%7.82K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Akanda Corp. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 205 | $2.81K | 0.00% | −2,069−91.0% | Reduced |
| Wells Fargo & Company | 13 | $178 | 0.00% | +13 | New |
| Morgan Stanley | 2 | $27 | 0.00% | +2 | New |